Home140410 • KOSDAQ
add
Mezzion Pharma Co Ltd
Previous close
₩30,000.00
Day range
₩30,000.00 - ₩31,000.00
Year range
₩27,000.00 - ₩50,200.00
Market cap
903.39B KRW
Avg Volume
106.00K
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Investopedia
1 hour ago
S&P 500 Gains and Losses Today: Eli Lilly Stock Falls as Sales Outlook
Weakens
0.11%
Financials
Income Statement
Revenue
Net income
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.26B | -73.18% |
Operating expense | 2.17B | -52.12% |
Net income | -6.33B | -547.58% |
Net profit margin | -280.10 | -2,314.66% |
Earnings per share | — | — |
EBITDA | -1.44B | 50.51% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 34.73B | -46.16% |
Total assets | 74.24B | -20.52% |
Total liabilities | 20.47B | -30.64% |
Total equity | 53.76B | — |
Shares outstanding | 29.96M | — |
Price to book | 16.72 | — |
Return on assets | -5.47% | — |
Return on capital | -7.47% | — |
Cash Flow
Net change in cash
| (KRW) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -6.33B | -547.58% |
Cash from operations | -2.38B | -150.27% |
Cash from investing | -1.91B | 65.67% |
Cash from financing | 912.05M | 282.11% |
Net change in cash | -3.40B | -128.44% |
Free cash flow | -7.49B | -28,356.55% |
About
CEO
Founded
2002
Website
Employees
17
